Database studies in post-marketing surveillance in Japan: Perspective from the industry

DOI Web Site
  • Aoki Kotonari
    Real World Data Science Dept., Chugai Pharmaceutical Co., LTD., Japan

Description

<p>It can be said that April 1, 2018 is an anniversary on which drug epidemiology was fully introduced in Japanese pharmacovigilance activities. It can also be said that the concept of comparing treatment options and the secondary use of medical data are &quot;welcomed&quot; from the administrative side, Independence Day. Well, 3 months after that, how did Japanese pharmacovigilance begin to change? I would like to outline this from the standpoint of a pharmaceutical company employee and look forward to the future - with optimism hope.</p>

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top